Our group has previously demonstrated that mutations in the translation initiation codon of ELANE, a mutation associated with resistance to G-CSF administration (6–8), result in neutropenia, through the expression of alternative, truncated, misfolded peptides by cistrons initiated by alternative translation start codons and internal ribosomal entry sites (12). The gene discussed is CSF3; the disease is neutropenia.